Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ossur Hf : New share option program

Posted on: 08 Mar 18

Announcement no. 19/2018
Reykjavik, 8 March 2018 

New share option program

Enclosed information on a new share option program for the CEO and other members of the Executive Management, their direct reports (with exceptions) and key specialists in strategic positions.

The key terms and conditions of the program were approved by the Annual General Meeting on 8 March 2018 in accordance with the Company's Remuneration Policy.

Further information

David Hreidarsson
Investor Relations
+354 515 1380

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations.  Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy.  A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, EMEA and APAC, with additional distributors worldwide.



Last updated on: 08/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.